Immune Checkpoint Inhibitors: New Weapons Against Medullary Thyroid Cancer?

由 Di Molfetta, Sergio, Dotto, Andrea, Fanciulli, Giuseppe, Florio, Tullio, Feola, Tiziana, Colao, Annamaria, Faggiano, Antongiulio
發表在 Front Endocrinol (Lausanne) (2021)

Commentary: Case Report: Abdominal Lymph Node Metastases of Parathyroid Carcinoma: Diagnostic Workup, Molecular Diagnosis, and Clinical Management

由 Fanciulli, Giuseppe, Di Molfetta, Sergio, Dotto, Andrea, Florio, Tullio, Feola, Tiziana, Colao, Annamaria, Faggiano, Antongiulio
發表在 Front Endocrinol (Lausanne) (2021)

Efficacy and safety of flash glucose monitoring in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis

由 Castellana, Marco, Parisi, Claudia, Di Molfetta, Sergio, Di Gioia, Ludovico, Natalicchio, Annalisa, Perrini, Sebastio, Cignarelli, Angelo, Laviola, Luigi, Giorgino, Francesco
發表在 BMJ Open Diabetes Res Care (2020)

Emerging Therapies in Pheochromocytoma and Paraganglioma: Immune Checkpoint Inhibitors in the Starting Blocks

由 Fanciulli, Giuseppe, Di Molfetta, Sergio, Dotto, Andrea, Florio, Tullio, Feola, Tiziana, Rubino, Manila, de Cicco, Federica, Colao, Annamaria, Faggiano, Antongiulio
發表在 J Clin Med (2020)

Clinical use of a 180‐day implantable glucose sensor improves glycated haemoglobin and time in range in patients with type 1 diabetes

由 Irace, Concetta, Cutruzzolà, Antonio, Nuzzi, Annamaria, Assaloni, Roberta, Brunato, Barbara, Pitocco, Dario, Tartaglione, Linda, Di Molfetta, Sergio, Cignarelli, Angelo, Laviola, Luigi, Citro, Giuseppe, Lovati, Elisabetta, Gnasso, Agostino, Tweden, Katherine S, Kaufman, Francine R
發表在 Diabetes Obes Metab (2020)